Tomoyuki Shishido
- Immunology and Allergy top 5%
- Cell Biology top 10%
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments 8
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
-
- Protein Kinase Regulation and GTPase Signaling 6
- PI3K/AKT/mTOR signaling in cancer 3
- Melanoma and MAPK Pathways 2
-
- Fungal Plant Pathogen Control 3
-
- Orthopaedic implants and arthroplasty 2
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- Hidesaburô HanafusaTsuyoshi AkagiMaria-Magdalena GeorgescuKathrin H. KirschKazutaka MurataKatsuko TaniSeiichi SatoChen Zong
- Journals
- FEBS Letters (3 papers)Oncogene (3 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Tomoyuki Shishido
23 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 89
- Immunology and Allergy 91
- Cell Biology 188
- Hematology 122
- Genetics 105
- Molecular Biology 676
Countries citing papers authored by Tomoyuki Shishido
This map shows the geographic impact of Tomoyuki Shishido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Shishido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Shishido more than expected).
Fields of papers citing papers by Tomoyuki Shishido
This network shows the impact of papers produced by Tomoyuki Shishido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Shishido. The network helps show where Tomoyuki Shishido may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomoyuki Shishido, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2008 | 12 | |
| 4 | 2007 | 10 | |
| 5 | 2006 | 18 | |
| 6 | 2006 | 8 | |
| 7 | 2006 | 6 | |
| 8 | 2005 | 26 | |
| 9 | 2004 | 16 | |
| 10 | 2003 | 41 | |
| 11 | 2003 | 14 | |
| 12 | 2003 | 84 | |
| 13 | 2002 | 59 | |
| 14 | 2001 | 48 | |
| 15 | 2001 | 74 | |
| 16 | [Adenocarcinoma of the renal pelvis and transitional cell carcinoma of the ureter occurring 11 years after radical cystectomy for bladder cancer: a case report]. | 2001 | 1 |
| 17 | 2000 | 23 | |
| 18 | 1999 | 285 | |
| 19 | 1999 | 80 | |
| 20 | 1998 | 68 |
About Tomoyuki Shishido
Tomoyuki Shishido is a scholar working on Hematology, Immunology and Allergy and Genetics, having authored 23 papers that have together received 1.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Fungal Plant Pathogen Control (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Orthopaedic implants and arthroplasty (2 papers), Cancer Mechanisms and Therapy (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Immunology and Allergy (91 citations), Cell Biology (188 citations) and Hematology (122 citations). Tomoyuki Shishido has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Hidesaburô Hanafusa, Tsuyoshi Akagi, Maria-Magdalena Georgescu, Kathrin H. Kirsch, Kazutaka Murata, Katsuko Tani, Seiichi Sato, Chen Zong, Wallace Y. Langdon and Taiko Sukezane. Their work appears in journals such as FEBS Letters, Oncogene, Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.